Guggenheim Capital’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
2015
Q1
$8M Buy
2014
Q4
$5.92M Sell
2014
Q3
$4.51M Buy
2014
Q2
$5.59M Sell
2014
Q1
$5.03M Sell
2013
Q4
$4.05M Buy